Azitra (AZTR) Change in Accured Expenses (2022 - 2026)
Azitra (AZTR) reported Change in Accured Expenses of $542064.0 for Q1 2026, up 933.44% on a YoY basis from $52452.2 in Q1 2025, and up 191.28% quarter-over-quarter from -$593872.0 in Q4 2025.
Azitra (AZTR) Change in Accured Expenses (2022 - 2026) Analysis & Trends
Azitra has reported Change in Accured Expenses for 5 years, with the latest figure at $542064.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 933.44% year-over-year to $542064.0; the trailing twelve-month figure through Mar 2026 stood at $106785.0 (up 41.4% YoY), and the FY2025 full-year result was -$500318.0, down 256.01% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $542064.0, up from -$593872.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $542064.0 in Q1 2026, with the low at -$593872.0 in Q4 2025.
- Historically, Change in Accured Expenses has averaged $7950.1 across 5 years, with a median of $24845.0 in 2024.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses tumbled 5430.88% — and 2026, when it surged 933.44%.
- Azitra's Change in Accured Expenses stood at $422616.0 in 2022, then slumped by 82.26% to $74978.0 in 2023, then tumbled by 66.86% to $24845.0 in 2024, then slumped by 2490.31% to -$593872.0 in 2025, then soared by 191.28% to $542064.0 in 2026.
- The last three Change in Accured Expenses figures came in at $542064.0 (Q1 2026), -$593872.0 (Q4 2025), and $53122.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 931,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | 542,064.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 542,064.00 |
| Mar 31, 2026 | 542,064.00 |
| Dec 31, 2025 | -593,872.00 |
| Dec 31, 2025 | -593,872.00 |
| Sep 30, 2025 | 53,122.00 |
| Sep 30, 2025 | 53,122.00 |
| Jun 30, 2025 | 105,471.00 |
| Jun 30, 2025 | 105,471.00 |
| Mar 31, 2025 | -65,039.00 |
| Mar 31, 2025 | -65,039.00 |
| Dec 31, 2024 | 24,845.00 |
| Dec 31, 2024 | 24,845.00 |
| Sep 30, 2024 | -326,143.00 |
| Sep 30, 2024 | -326,143.00 |
| Jun 30, 2024 | 441,859.00 |
| Jun 30, 2024 | 441,859.00 |
| Mar 31, 2024 | -281,096.00 |
| Mar 31, 2024 | -281,096.00 |
| Dec 31, 2023 | 74,978.00 |
| Dec 31, 2023 | 74,978.00 |